Ipca Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

25.37

25.37

25.37

25.27

25.27

Share application money

-

-

-

11.94

-

Preference share capital

-

-

-

-

-

Reserves & surplus

5,851.93

5,497.97

4,727.35

3,640.33

3,111.39

Loan funds

Secured loans

1,422.61

761.01

223.20

387.65

329.80

Unsecured loans

-

-

-

-

-

Total

7,299.91

6,284.35

4,975.92

4,065.19

3,466.46

Uses of funds

Fixed assets

Gross block

3,817.97

3,210.57

2,822.88

2,632.80

2,373.28

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

1,339.31

1,125.79

954.28

791.83

633.18

Net block

2,478.66

2,084.78

1,868.60

1,840.97

1,740.10

Capital work-in-progress

123.02

289.04

182.00

84.19

65.96

Investments

1,056.73

1,447.52

867.84

648.72

322.24

Net current assets

Current assets, loans & advances

4,788.56

3,645.52

3,091.69

2,610.69

2,329.24

Less : current liabilities & provisions

1,147.06

1,182.51

1,034.21

1,119.38

991.08

Total net current assets

3,641.50

2,463.01

2,057.48

1,491.31

1,338.16

Miscellaneous expenses not written

-

-

-

-

-

Total

7,299.91

6,284.35

4,975.92

4,065.19

3,466.46

Notes:

Book value of unquoted investments

25.41

25.19

-

-

-

Market value of quoted investments

323.32

719.31

393.83

238.25

90.38

Contingent liabilities

2,161.85

287.71

382.20

219.49

164.84

Number of equity sharesoutstanding (Lacs)

2537.04

2537.04

1268.52

1263.52

1263.52